Illumina Accelerator is accepting applications for its next funding cycle in San Francisco. Illumina Accelerator is the world’s first business accelerator focused on creating an innovation ecosystem for the genomics industry. It drives value for genomics startups developing breakthrough applications in therapeutics, diagnostics, agriculture, direct to consumer, synthetic biology, and beyond. Selected genomics startups will receive seed investment, business guidance, and fully operational lab space for six months in San Francisco, starting in January 2017. Applications for the fifth funding cycle are due by September 1, 2016.